Market Cap 66.95M
Revenue (ttm) 7.01M
Net Income (ttm) -32.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -456.63%
Debt to Equity Ratio 0.00
Volume 6,417
Avg Vol 57,898
Day's Range N/A - N/A
Shares Out 42.37M
Stochastic %K 47%
Beta 0.72
Analysts Strong Sell
Price Target $4.50

Company Profile

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as w...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 776 6804
Address:
6303 Waterford District Drive, Suite 215, Miami, United States
zigsfrd
zigsfrd Feb. 4 at 4:17 PM
$NSPR I don't think Gleason selling shares means a damn thing, other than pocket change for him. With this company more than 80% owned by tutes and insiders, with limited liquidity. The name your price and volume aspect of trading reminds me of a privately held company that will sell, but only for a certain prespecified price.
0 · Reply
Shadowsdontlie
Shadowsdontlie Feb. 4 at 3:47 PM
$NSPR Sell the company. That is the answer. Sell the Company while there is still cash in the bank and gleam its eye. Sell the company. Typically a long quiet period like NSPR is indicates those talks could be real. With NSPR the problem is they have never been good at communication so its hard to tell what is happening from silence. Its more the norm than not. Sell the company.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 9:43 AM
$NSPR Excellent article that nails exactly where NSPR stands right now. So if you want to update your NSPR knowledge or get acquainted with NSPR, this is a must read. https://everyticker.com/quote/NSPR/analysis/inspiremd-micronet-technology-poised-for-u-s-market-entry-amidst-liquidity-headwinds-nasdaq-nspr
1 · Reply
Threeways
Threeways Feb. 3 at 5:48 PM
$NSPR Shane Gleason is scum. Puts a bad sentiment on the stock by selling when he gets paid a high salary already. Hell he sucks at even selling their product so why are we even giving him millions in shares at the expense of us. Fleecing Gleason is a douche canoe
2 · Reply
Jonnie5
Jonnie5 Feb. 3 at 5:38 PM
$NSPR same old song here.
0 · Reply
woodstockery
woodstockery Feb. 3 at 3:50 PM
$NSPR feeling pretty unNSPRd atm
0 · Reply
Shadowsdontlie
Shadowsdontlie Feb. 3 at 2:59 PM
$NSPR Wonder if Slosman realizes you can not buy NSPR at Fidelity or Schwab without placing a phone call to the trading desk. At Fidelity, you can only sell a Fidelity algo chosen amount of stock . You have 10,000 shares and want to sell at Fidelity? Their system won't do the trade. Call the desk and they too can only sell a few shares at a time. Seriously small amount even if the volume that day is off the charts up. Schwab you can sell, but its the buying that presents road blocks. SO. You , me. Are in a stock that the first thing that ahppens when you want to buy gets a red flag thrown up. Just like a pink sheet stock. Then want to sell? You cant . The problem is not the company. The problem is the liquidity that is lacking. There is so little retail ownership that the hedge funds, institutions, private equity, RA's can not get in the stock without moving the market and cant get out when they are in so they 'don't' do either. They cant.
0 · Reply
HOBOWITHASHOTGUN
HOBOWITHASHOTGUN Feb. 3 at 1:47 PM
1 · Reply
arcuy
arcuy Feb. 3 at 1:09 PM
$NSPR All the waiting and ups and downs since 2020 will pay off.
0 · Reply
Threeways
Threeways Feb. 2 at 1:57 PM
$NSPR Nice to see additional coverage from Maxim! Now where’s the TCAR clinical trial update?! This was supposed to be before the end of 2025????
1 · Reply
Latest News on NSPR
InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 1:06 PM EST - 3 months ago

InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript


InspireMD Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 7:00 AM EST - 3 months ago

InspireMD Reports Third Quarter 2025 Financial Results


InspireMD Names Peter A. Soukas, M.D.

Nov 3, 2025, 7:30 AM EST - 3 months ago

InspireMD Names Peter A. Soukas, M.D.


InspireMD to Announce Third Quarter 2025 Financial Results

Oct 21, 2025, 4:05 PM EDT - 3 months ago

InspireMD to Announce Third Quarter 2025 Financial Results


InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:30 PM EDT - 6 months ago

InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript


InspireMD Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 8:00 AM EDT - 6 months ago

InspireMD Reports Second Quarter 2025 Financial Results


InspireMD Announces Combined Financings of $58 Million

Jul 31, 2025, 8:30 AM EDT - 6 months ago

InspireMD Announces Combined Financings of $58 Million


InspireMD to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:00 AM EDT - 7 months ago

InspireMD to Announce Second Quarter 2025 Financial Results


InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript

May 9, 2025, 12:07 PM EDT - 9 months ago

InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript


InspireMD Reports First Quarter 2025 Financial Results

May 9, 2025, 7:00 AM EDT - 9 months ago

InspireMD Reports First Quarter 2025 Financial Results


InspireMD to Announce First Quarter 2025 Financial Results

Apr 25, 2025, 9:00 AM EDT - 10 months ago

InspireMD to Announce First Quarter 2025 Financial Results


InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 1:53 PM EDT - 11 months ago

InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript


InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:20 AM EST - 1 year ago

InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript


InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:58 AM EDT - 1 year ago

InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript


InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript

May 14, 2024, 10:50 AM EDT - 1 year ago

InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript


InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 11:30 AM EST - 2 years ago

InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript


zigsfrd
zigsfrd Feb. 4 at 4:17 PM
$NSPR I don't think Gleason selling shares means a damn thing, other than pocket change for him. With this company more than 80% owned by tutes and insiders, with limited liquidity. The name your price and volume aspect of trading reminds me of a privately held company that will sell, but only for a certain prespecified price.
0 · Reply
Shadowsdontlie
Shadowsdontlie Feb. 4 at 3:47 PM
$NSPR Sell the company. That is the answer. Sell the Company while there is still cash in the bank and gleam its eye. Sell the company. Typically a long quiet period like NSPR is indicates those talks could be real. With NSPR the problem is they have never been good at communication so its hard to tell what is happening from silence. Its more the norm than not. Sell the company.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 9:43 AM
$NSPR Excellent article that nails exactly where NSPR stands right now. So if you want to update your NSPR knowledge or get acquainted with NSPR, this is a must read. https://everyticker.com/quote/NSPR/analysis/inspiremd-micronet-technology-poised-for-u-s-market-entry-amidst-liquidity-headwinds-nasdaq-nspr
1 · Reply
Threeways
Threeways Feb. 3 at 5:48 PM
$NSPR Shane Gleason is scum. Puts a bad sentiment on the stock by selling when he gets paid a high salary already. Hell he sucks at even selling their product so why are we even giving him millions in shares at the expense of us. Fleecing Gleason is a douche canoe
2 · Reply
Jonnie5
Jonnie5 Feb. 3 at 5:38 PM
$NSPR same old song here.
0 · Reply
woodstockery
woodstockery Feb. 3 at 3:50 PM
$NSPR feeling pretty unNSPRd atm
0 · Reply
Shadowsdontlie
Shadowsdontlie Feb. 3 at 2:59 PM
$NSPR Wonder if Slosman realizes you can not buy NSPR at Fidelity or Schwab without placing a phone call to the trading desk. At Fidelity, you can only sell a Fidelity algo chosen amount of stock . You have 10,000 shares and want to sell at Fidelity? Their system won't do the trade. Call the desk and they too can only sell a few shares at a time. Seriously small amount even if the volume that day is off the charts up. Schwab you can sell, but its the buying that presents road blocks. SO. You , me. Are in a stock that the first thing that ahppens when you want to buy gets a red flag thrown up. Just like a pink sheet stock. Then want to sell? You cant . The problem is not the company. The problem is the liquidity that is lacking. There is so little retail ownership that the hedge funds, institutions, private equity, RA's can not get in the stock without moving the market and cant get out when they are in so they 'don't' do either. They cant.
0 · Reply
HOBOWITHASHOTGUN
HOBOWITHASHOTGUN Feb. 3 at 1:47 PM
1 · Reply
arcuy
arcuy Feb. 3 at 1:09 PM
$NSPR All the waiting and ups and downs since 2020 will pay off.
0 · Reply
Threeways
Threeways Feb. 2 at 1:57 PM
$NSPR Nice to see additional coverage from Maxim! Now where’s the TCAR clinical trial update?! This was supposed to be before the end of 2025????
1 · Reply
Shadowsdontlie
Shadowsdontlie Jan. 30 at 8:23 PM
0 · Reply
trek10
trek10 Jan. 29 at 9:58 PM
$NSPR Neutral bias prevailing
0 · Reply
Threeways
Threeways Jan. 28 at 5:51 PM
$NSPR looking at the brighter side. The first quarter of US sales was $500K more than any of their other markets by far. If they can double each quarter (if not slightly more than double) they should be profitable by EOY. Lets hope for 1 million in US sales from Q4
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 25 at 3:40 AM
$NSPR RSI: 33.33, MACD: -0.0876 Vol: 0.15, MA20: 1.75, MA50: 1.86 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
zigsfrd
zigsfrd Jan. 23 at 10:42 PM
$NSPR Are these men of science avoiding a sexual harassment suit?😂😂😂
0 · Reply
Threeways
Threeways Jan. 22 at 6:17 PM
$NSPR i’ve been wondering. Why would they accelerate kathryn Arnolds equity awards for resigning? Seems wild to me unless she was pushed out.
2 · Reply
woodstockery
woodstockery Jan. 21 at 3:49 PM
$NSPR nvm
0 · Reply
woodstockery
woodstockery Jan. 21 at 3:02 PM
$NSPR do my eyes deceive me?
0 · Reply
Jerry000
Jerry000 Jan. 20 at 7:26 PM
$NSPR It's been awhile since I have posted. This is the trial that I have been involved in on the Gguard stent.https://clinicaltrials.gov/study/NCT06653387?term=CGuard%20Prime%20Carotid%20Stent%20System&rank=1c I was the third person in the Cincinnati area at TriHealth by Dr. Muck to have this procedure in February 2025 I just wanted to give an update after talking with the doctor and the research company that everything has been excellent and the research company told me that they have excellent reviews on this particular study. My annual visit with the research company and the doctor is in the 1st of February of 2026 which will conclude the research on me. I am not trying to hype anything other than to give an update. With a little research on the link that I provided, they have three different studies going on. Maybe their will be good news soon
2 · Reply
DocRosen
DocRosen Jan. 20 at 6:06 PM
$NSPR good to see some volume today
1 · Reply
Threeways
Threeways Jan. 19 at 9:01 PM
$NSPR updated investor presentation states over 70,000 stents sold to date up 5,000 stents from last presentation. Will sales be a nice surprise or just slightly better; ready to see
0 · Reply
TrkDvr
TrkDvr Jan. 16 at 6:19 PM
$NSPR Hey, I own a bunch of this stock. So here's what's good about it. Big cash balance with a D/E of 5.26%. Biggest problem seems to be very weak sales & a EBITDA of $-46.49M. I think a practical sales program to offset this current operating loss would definitely excite the market. We don't need a quarterly report to update shareholders on unit sales. This can be done monthly. Make it happen!
1 · Reply